Journals / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 6

Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation

Pages
495–498
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Data is still scant at this point, however, what is available suggests a promising opportunity for future studies to expand upon what has been demonstrated

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Many disease processes lead to chronic liver disease, however, progress has been made regarding common findings amongst these disease processes that may suggest a path forward for treatment.
📊
Key Findings & Data:In particular, common alterations in the intestinal microflora of patients with different etiologies of liver disease may provide a clue as to the pathogenesis of these disorders as well a potential therapy.
💡
Conclusion & Impact:Data is still scant at this point, however, what is available suggests a promising opportunity for future studies to expand upon what has been demonstrated
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Many disease processes lead to chronic liver disease, however, progress has been made regarding common findings amongst these disease processes that may suggest a path forward for treatment. In particular, common alterations in the intestinal microflora of patients with different etiologies of liver disease may provide a clue as to the pathogenesis of these disorders as well a potential therapy. Data is still scant at this point, however, what is available suggests a promising opportunity for future studies to expand upon what has been demonstrated

🔖

Cite This Article

HEATH, R. D., MİR, F., IBDAH, J. A., TAHAN, V. (2016). Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 6, 495–498. https://ajindex.com/articles/409357

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Duncan SH, Louis P, Flint HJ. Cultivable bacterial diversity from the human colon. Lett in Appl Microbiol 2007; 44: 343-50. [CrossRef] Rashid MU, Zaura E, Buijs MJ, et al. Determining the long-term effect of antibiotic administration on the human normal intesti- nal microbiota using culture and pyrosequencing methods. Clin Infect Dis 2015; 60 (Suppl 2): S77-84. [CrossRef] Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197: 435-8. [CrossRef] Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015; 7: 1679-84. [CrossRef] Bajaj JS, Heuman DM, Hylemon PB, et al. The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cir- rhosis and its Complications. J Hepatol 2014; 60: 940-7. [CrossRef] Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59-64. [CrossRef] Backhed F. Programming of host metabolism by the gut micro- biota. Ann Nutr Metab 2011; 58: 44-52. [CrossRef] Bakulin I, Shalikiani N, Alexeev D, Govorun V. 1099 Changes in taxonomy and functions of the gut microbiome in patients with alcoholic liver cirrhosis: New data. Gastroenterology 2016; 150: S220. [CrossRef] Bajaj J, Sterling RK, Betrapally NS, et al. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic pa- tients. Aliment Pharmacol Ther 2016; 44: 638-43. [CrossRef] Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastroin- test Liver Physiol 2012; 302: G168-75. [CrossRef] Nava GM, Stappenbeck TS. Diversity of the autochthonous co- lonic microbiota. Gut 2011; 2: 99-104. [CrossRef] Kang, DJ, Hylemon PB, Bajaj J. Fecal transplant to mitigate hyper- ammonemia and hepatic encephalopathy in animal models. Ann Hepatol 2015; 14: 762-3.
  2. Quigley EM, Monsour HP. The gut microbiome and the liver: im- plications for clinical practice. Expert Rev Gastroenterol Hepatol 2013; 7: 723-32. [CrossRef] Ley RE1, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gor- don JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070-5. [CrossRef] López-Cepero AA, Palacios C. Association of the intestinal micro- biota and obesity. P R Health Sci J 2015; 34: 60-4.
  3. Kallus SJ, Brandt LJ. The intestinal microbiota and